ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in February 2021. Updated February 28.
A roundup of FDA’s actions in February 2021.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and Diagnostic Emergency Use Authorizations in February 2021. Updated February 28.
A roundup of FDA’s actions in February 2021.